PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1808916
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1808916
Toxoplasmosis Testing Market, By Product Type, By Test Type, By Technology, By Sample Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
Toxoplasmosis Testing Market size was valued at US$ 1,267 Million in 2024, expanding at a CAGR of 9.1% from 2025 to 2032.
The Toxoplasmosis Testing Market involves diagnostic procedures to detect Toxoplasma gondii infection, primarily through serological and molecular tests. Market growth is driven by increasing cases of toxoplasmosis in immunocompromised patients, pregnant women, and organ transplant recipients, especially in regions with limited sanitation and awareness. Rising prenatal screening initiatives, particularly in Europe and South America, and the use of nucleic acid amplification tests (NAATs) in diagnostic labs are bolstering demand. However, the market faces restraints such as underreporting, limited public health surveillance, and inconsistent testing practices in low-income regions. On the opportunity front, growing R&D funding, technological improvements in PCR and ELISA platforms, and collaborations between diagnostic companies and public health agencies (e.g., CDC and WHO) are expected to support market expansion over the coming years.
Toxoplasmosis Testing Market- Market Dynamics
Rising Prenatal Screening and Diagnostic Advancements Fuel Toxoplasmosis Testing Market Growth
The toxoplasmosis testing market is gaining momentum due to the increasing emphasis on prenatal care and infectious disease management. According to the CDC, toxoplasmosis affects over 40 million people in the U.S., though most remain asymptomatic. Pregnant women and immunocompromised individuals are particularly at risk, prompting regular screening protocols in countries like France, Austria, and Brazil. In 2023, the European Centre for Disease Prevention and Control (ECDC) highlighted rising awareness campaigns and improved diagnostics in Eastern Europe to reduce congenital infections. Simultaneously, initiatives like the WHO's efforts on foodborne parasitic diseases have led to improved public health strategies, especially in developing nations. Growing collaborations between diagnostic labs and hospitals, such as standardized serological testing in public health clinics, are also contributing to market expansion.
Toxoplasmosis Testing Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.1% over the forecast period (2025-2032)
Based on product type segmentation, Test kits were predicted to show maximum market share in the year 2024
Based on Test Type segmentation, Serological tests were the leading Test Type in 2024
Based on Technology segmentation, Enzyme-Linked Immunosorbent Assay (ELISA) was the leading Technology in 2024
Based on Sample Type segmentation, Blood was the leading Sample Type in 2024
Based on end user segmentation, Hospitals were the leading end user in 2024
On the basis of region, North America was the leading revenue generator in 2024
Toxoplasmosis Testing Market- Segmentation Analysis:
The Global Toxoplasmosis Testing Market is segmented on the basis of Product Type, Test Type, Technology, Sample Type, End User, and Region.
The market is divided into four categories based on product type: Test Kits, Reagents, Instruments and Analyzers, and Software Solutions. Test kits held the highest priority due to their widespread use in clinical and point-of-care diagnostics. Reagents followed, driven by recurring demand. Instruments and analyzers ranked next, while software solutions held a supportive yet emerging role in result interpretation.
The market is divided into three categories based on Test Type: Serological Tests, Molecular Tests, Histological Tests, and Other. Serological tests led the market due to their cost-effectiveness and broad clinical use. Molecular tests followed closely with rising adoption in reference labs. Histological tests were less preferred, while other test types held minimal market share.
Toxoplasmosis Testing Market- Geographical Insights
In Europe, countries such as France and Austria have implemented routine prenatal toxoplasmosis screening programs, significantly boosting early diagnosis and driving market development. According to the European Centre for Disease Prevention and Control (ECDC), congenital toxoplasmosis remains a critical focus in public health strategies, especially in Eastern Europe, where infection rates are higher. In North America, the CDC promotes awareness and preventive testing among pregnant women and immunocompromised individuals, supported by collaborations with public health departments and diagnostic labs. In Brazil, the Ministry of Health has strengthened toxoplasmosis surveillance under its congenital infection control program, enhancing access to diagnostic services in public hospitals. In 2024, collaborations between university hospitals and diagnostic reagent providers were reported in Brazil and Argentina to advance localized serology development. These region-specific initiatives and institutional alliances are steadily contributing to the improved detection and control of toxoplasmosis across global healthcare systems.
Toxoplasmosis Testing Market- Competitive Landscape:
The toxoplasmosis testing market is moderately competitive, with several diagnostic firms and research institutions focused on enhancing test sensitivity and affordability. Key players like Bio-Rad Laboratories, Abbott, and DiaSorin continue to advance serological assay development in collaboration with academic and public health institutions. In 2024, DiaSorin partnered with the University of Milan to refine IgG avidity testing for early toxoplasmosis detection in pregnancy. Similarly, the Pasteur Institute has collaborated with diagnostic startups in France to support rapid test kit innovation for low-resource settings. Meanwhile, Abbott expanded its molecular diagnostics division by integrating pathogen-specific PCR platforms to cover parasitic infections, including T. gondii. On the regional level, Brazil's Fiocruz has worked with local biotech firms to produce ELISA test kits, reducing reliance on imported diagnostics. Such strategic alliances and public-private partnerships are strengthening the global testing infrastructure and accelerating the adoption of more efficient toxoplasmosis diagnostics.
Recent Developments:
In May 2024, the University of Chicago and LDBIO Diagnostics introduced a rapid point-of-care test, the Toxoplasma ICT IgG-IgM, offering accurate detection within 30 minutes from a finger-prick, with over 97.5% sensitivity and 100% specificity, effectively reducing false positives and improving prenatal screening accuracy.
In May 2025, scientists at the National Institute of Animal Biotechnology (NIAB) in Hyderabad used CRISPR-based genetic manipulation to pinpoint a Toxoplasma gondii protein that could be key in preventing zoonotic transmission and congenital toxoplasmosis-an effort aligned with WHO and FAO priorities on foodborne parasitic diseases.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL TOXOPLASMOSIS TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- ARUP Laboratories
- Becton, Dickinson and Company
- bioMerieux
- Bio-Rad Laboratories
- Creative Diagnostics
- Danaher Corporation
- DiaSorin
- F. Hoffmann-La Roche
- Luminex Corporation
- NovaTec Immundiagnostica
- Omega Diagnostics
- Ortho Clinical Diagnostics
- QIAGEN
- Randox Laboratories
- Siemens Healthineers
- Thermo Fisher Scientific
- Trinity Biotech
- Vircell
- ZEUS Scientific
- Others
GLOBAL TOXOPLASMOSIS TESTING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Test Kits
- Reagents
- Instruments and Analyzers
- Software Solutions
GLOBAL TOXOPLASMOSIS TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
- Serological Tests
- Molecular Tests
- Histological Tests
- Other
GLOBAL TOXOPLASMOSIS TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Polymerase Chain Reaction (PCR)
- Others
GLOBAL TOXOPLASMOSIS TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032
- Blood
- Amniotic Fluid
- Cerebrospinal Fluid
- Other
GLOBAL TOXOPLASMOSIS TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic Laboratories
- Research Institutions
- Homecare Settings
GLOBAL TOXOPLASMOSIS TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Toxoplasmosis Testing Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Toxoplasmosis Testing Market Snippet by Product Type
- 2.1.2. Toxoplasmosis Testing Market Snippet by Test Type
- 2.1.3. Toxoplasmosis Testing Market Snippet by Technology
- 2.1.4. Toxoplasmosis Testing Market Snippet by Sample Type
- 2.1.5. Toxoplasmosis Testing Market Snippet by End User
- 2.1.6. Toxoplasmosis Testing Market Snippet by Country
- 2.1.7. Toxoplasmosis Testing Market Snippet by Region
- 2.2. Competitive Insights
3. Toxoplasmosis Testing Key Market Trends
- 3.1. Toxoplasmosis Testing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Toxoplasmosis Testing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Toxoplasmosis Testing Market Opportunities
- 3.4. Toxoplasmosis Testing Market Future Trends
4. Toxoplasmosis Testing Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Toxoplasmosis Testing Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Toxoplasmosis Testing Market Landscape
- 6.1. Toxoplasmosis Testing Market Share Analysis, 2024
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Toxoplasmosis Testing Market - By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Test Kits
- 7.1.3. Reagents
- 7.1.4. Instruments and Analyzers
- 7.1.5. Software Solutions
8. Toxoplasmosis Testing Market - By Test Type
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
- 8.1.2. Serological Tests
- 8.1.3. Molecular Tests
- 8.1.4. Histological Tests
- 8.1.5. Other
9. Toxoplasmosis Testing Market - By Technology
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
- 9.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 9.1.3. Polymerase Chain Reaction (PCR)
- 9.1.4. Others
10. Toxoplasmosis Testing Market - By Sample Type
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Sample Type, 2024 & 2032 (%)
- 10.1.2. Blood
- 10.1.3. Amniotic Fluid
- 10.1.4. Cerebrospinal Fluid
- 10.1.5. Other Body Fluids
11. Toxoplasmosis Testing Market - By End User
- 11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 11.1.2. Hospitals
- 11.1.3. Diagnostic Laboratories
- 11.1.4. Research Institutions
- 11.1.5. Homecare Settings
12. Toxoplasmosis Testing Market- By Geography
- 12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
- 12.2. North America
- 12.2.1. Overview
- 12.2.2. Toxoplasmosis Testing Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
- 12.2.9.1. Overview
- 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.2.9.4. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.2.9.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.2.9.6. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
- 12.2.10.1. Overview
- 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.2.10.4. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.2.10.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.2.10.6. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3. Europe
- 12.3.1. Overview
- 12.3.2. Toxoplasmosis Testing Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
- 12.3.9.1. Overview
- 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.9.4. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.3.9.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.9.6. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.10. UK
- 12.3.10.1. Overview
- 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.10.4. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.3.10.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.10.6. UK Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.11. France
- 12.3.11.1. Overview
- 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.11.4. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.3.11.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.11.6. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.12. Italy
- 12.3.12.1. Overview
- 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.12.4. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.3.12.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.12.6. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.13. Spain
- 12.3.13.1. Overview
- 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.13.4. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.3.13.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.13.6. Spain Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.14. The Netherlands
- 12.3.14.1. Overview
- 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.14.4. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.14.6. The Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
- 12.3.15.1. Overview
- 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.15.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.3.15.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.15.6. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.16. Russia
- 12.3.16.1. Overview
- 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.16.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.3.16.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.16.6. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.17. Poland
- 12.3.17.1. Overview
- 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.17.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.3.17.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.17.6. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.18. Rest of Europe
- 12.3.18.1. Overview
- 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.18.4. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.18.6. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Toxoplasmosis Testing Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.9. China
- 12.4.9.1. Overview
- 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.9.4. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.4.9.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.9.6. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.10. India
- 12.4.10.1. Overview
- 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.10.4. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.4.10.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.10.6. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
- 12.4.11.1. Overview
- 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.11.4. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.4.11.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.11.6. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
- 12.4.12.1. Overview
- 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.12.4. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.4.12.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.12.6. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
- 12.4.13.1. Overview
- 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.13.4. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.4.13.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.13.6. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.14. Indonesia
- 12.4.14.1. Overview
- 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.14.4. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.14.6. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.15. Thailand
- 12.4.15.1. Overview
- 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.15.4. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.4.15.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.15.6. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
- 12.4.16.1. Overview
- 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.16.4. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.4.16.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.16.6. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
- 12.4.17.1. Overview
- 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.17.4. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.17.6. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Toxoplasmosis Testing Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
- 12.5.9.1. Overview
- 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.5.9.4. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.5.9.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.9.6. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
- 12.5.10.1. Overview
- 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.5.10.4. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.5.10.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.10.6. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
- 12.5.11.1. Overview
- 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.5.11.4. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.5.11.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.11.6. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
- 12.5.12.1. Overview
- 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.5.12.4. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.5.12.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.12.6. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
- 12.5.13.1. Overview
- 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.5.13.4. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.13.6. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Toxoplasmosis Testing Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
- 12.6.9.1. Overview
- 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.9.4. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.9.6. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
- 12.6.10.1. Overview
- 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.10.4. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.10.6. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
- 12.6.11.1. Overview
- 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.11.4. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.6.11.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.11.6. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
- 12.6.12.1. Overview
- 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.12.4. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.6.12.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.12.6. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
- 12.6.13.1. Overview
- 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.13.4. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.6.13.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.13.6. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
- 12.6.14.1. Overview
- 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.14.4. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.6.14.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.14.6. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
- 12.6.15.1. Overview
- 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.15.4. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.15.6. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Toxoplasmosis Testing Industry
- 13.1. Competitive Dashboard
- 13.1.1. Competitive Benchmarking
- 13.1.2. Competitive Positioning
- 13.2. Company Profiles
- 13.2.1. Abbott Laboratories
- 13.2.2. ARUP Laboratories
- 13.2.3. Becton, Dickinson and Company
- 13.2.4. bioMerieux
- 13.2.5. Bio-Rad Laboratories
- 13.2.6. Creative Diagnostics
- 13.2.7. Danaher Corporation
- 13.2.8. DiaSorin
- 13.2.9. F. Hoffmann-La Roche
- 13.2.10. Luminex Corporation
- 13.2.11. NovaTec Immundiagnostica
- 13.2.12. Omega Diagnostics
- 13.2.13. Ortho Clinical Diagnostics
- 13.2.14. QIAGEN
- 13.2.15. Randox Laboratories
- 13.2.16. Siemens Healthineers
- 13.2.17. Thermo Fisher Scientific
- 13.2.18. Trinity Biotech
- 13.2.19. Vircell
- 13.2.20. ZEUS Scientific
- 13.2.21. Others
14. 360 Degree Analyst View
15. Appendix
- 15.1. Research Methodology
- 15.2. References
- 15.3. Abbreviations
- 15.4. Disclaimer
- 15.5. Contact Us
